Tirzepatide is a next-generation dual incretin peptide that simultaneously activates both GLP-1 and GIP receptors — two key regulators of metabolic function. Extensively featured in high-impact research for its potency and selectivity, tirzepatide has become a gold-standard reference compound for scientists exploring advanced metabolic pathways.
Each preparation is lyophilized for maximum stability, independently verified at ≥98% purity by HPLC, and supplied with a Certificate of Analysis for every lot.
Reviews
There are no reviews yet.